MFN2 and hepatocellular carcinoma: In hepatoma cells, highly activated mTOR signaling increases the interaction of the M2 isoform of pyruvate kinase 2 (PKM2) and Mfn2 by phosphorylating Mfn2 and thereby inhibiting the activity of PKM2 and glycolysis.